The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two decades. Historically, therapeutic strategies primarily focused on suppressing ...

Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the field of ...

WARSAW/LONDON (Reuters) -Poland is working on a deal to import liquefied natural gas (LNG) from the U.S. to supply Ukraine and Slovakia, a pact that would further tighten the European Union’s ties to ...

Inflammatory bowel disease (IBD) is a crowded drug market with plenty of treatment options across the two forms of the gastrointestinal disease: ulcerative colitis and Crohn’s disease. But one ...